Orion OYJ (OTCMKTS:ORINY) Sets New 12-Month High – Should You Buy?

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $43.22 and last traded at $43.22, with a volume of 521 shares trading hands. The stock had previously closed at $38.54.

Orion OYJ Price Performance

The company has a current ratio of 1.77, a quick ratio of 1.13 and a debt-to-equity ratio of 0.10. The company has a 50 day simple moving average of $38.50 and a 200 day simple moving average of $38.77. The stock has a market cap of $12.20 billion, a P/E ratio of 17.79 and a beta of 0.08.

Orion OYJ (OTCMKTS:ORINY) last posted its quarterly earnings data on Friday, July 17th. The company reported $0.58 earnings per share (EPS) for the quarter. The company had revenue of $606.38 million for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 51.86%.

Orion OYJ Company Profile

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.